| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,417 |
7,482 |
$277K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,325 |
1,236 |
$94K |
| 88307 |
|
999 |
954 |
$54K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
968 |
955 |
$50K |
| 88342 |
|
1,698 |
1,516 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
508 |
473 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
256 |
236 |
$9K |
| 88341 |
|
209 |
183 |
$8K |
| 88112 |
|
80 |
68 |
$1K |
| 88304 |
|
114 |
110 |
$877.02 |
| 84165 |
|
96 |
82 |
$839.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
13 |
$325.00 |
| 85060 |
|
21 |
17 |
$260.30 |
| 88108 |
|
13 |
12 |
$160.48 |
| 80053 |
Comprehensive metabolic panel |
966 |
571 |
$20.20 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,391 |
703 |
$6.40 |
| 85610 |
|
42 |
17 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
25 |
25 |
$0.00 |
| 81001 |
|
162 |
151 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
218 |
81 |
$0.00 |
| 80069 |
|
26 |
12 |
$0.00 |
| 83735 |
|
64 |
19 |
$0.00 |
| 83605 |
|
28 |
13 |
$0.00 |
| 84484 |
|
19 |
14 |
$0.00 |